Samir Shah

Global Head Investor Relations at Novartis Venture Fund

Samir Shah

Samir Shah

Global Head Investor Relations at Novartis Venture Fund

Overview
RelSci Relationships

423

Relationships
RelSci Relationships are individuals Samir Shah likely has professional access to. A relationship does not necessarily indicate a personal connection.

Venture Partner at Novartis Venture Fund

Relationship likelihood: Strong

Head of Strategic Venture Capital Fund, Pharma Equities at Novartis AG

Relationship likelihood: Strong

Former President at Novartis Venture Fund

Relationship likelihood: Strong

Founder at Anokion SA

Relationship likelihood: Strong

Managing Director at Novartis Venture Fund

Relationship likelihood: Strong

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Chief Medical Officer at Novartis AG

Relationship likelihood: Strong

Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Executive Director at Novartis Venture Fund

Relationship likelihood: Strong

General Manager Region Europe Oncology at Novartis Venture Fund

Relationship likelihood: Strong

Paths to Samir Shah
Potential Connections via
Relationship Science
You
Samir Shah
Global Head Investor Relations at Novartis Venture Fund
Career History
Global Head Investor Relations
Current

NVF is an active venture capital investor focused on equity investments in Biotechnology/ Biopharma life sciences companies. It engages in seed investments as well as later-stage investments. It typically leads or co-leads an investment and plays an active role on company boards. The investment size is up to USD 30 million per company over its life. The investments are made in North America, Europe, Israel and in Asia/Pacific.

Investor Relations Contact
Current

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

Investor Relations Contact, Central
Current

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Samir Shah. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Samir Shah's profile does not indicate a business or promotional relationship of any kind between RelSci and Samir Shah.